Skip to content
  • ABOUT US
    • Our Core Values
    • Our Team
  • OUR SCIENCE
    • Our Technology
    • Our Clinical Candidates
    • Scientific Publications
  • CLINICAL RESEARCH
    • Pipeline
    • RESOLVE
  • PATIENTS
    • Eosinophilic Esophagitis
    • Expanded Access Program
  • CAREERS
  • INVESTORS
    • Overview
    • News
    • Events & Presentation
    • Stock Information
    • Financials
    • Governance
    • Resources
  • ABOUT US
    • Our Core Values
    • Our Team
  • OUR SCIENCE
    • Our Technology
    • Our Clinical Candidates
    • Scientific Publications
  • CLINICAL RESEARCH
    • Pipeline
    • RESOLVE
  • PATIENTS
    • Eosinophilic Esophagitis
    • Expanded Access Program
  • CAREERS
  • INVESTORS
    • Overview
    • News
    • Events & Presentation
    • Stock Information
    • Financials
    • Governance
    • Resources

Pharmacokinetic Profile of Intra-articular Fluticasone Propionate Microparticles in Beagle Dog Knees

Recent Posts

  • Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May
  • Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI
  • Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results
  • Eupraxia Pharmaceuticals to Host Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE) on May 9, 2025

Recent Comments

No comments to show.

Subscribe to our mailing list

Sign up

Eupraxia is a clinical-stage biotechnology company developing targeted therapies that leverage a proprietary extended-release delivery system to provide the right dose of a drug in the right place for the right amount of time.

Vancouver lab & office:
Eupraxia Pharmaceuticals
2198 Yukon St
Vancouver, BC V5Y 3P1
Canada

Seattle office:
Eupraxia Pharma USA Inc.
5310 Carillon Point
Kirkland, WA 98033
USA

Australia office:
Eupraxia Pharmaceuticals Australia Pty Ltd
Suite 1, Level 3, 62 Lygon Street
Carlton, VIC 3053
Australia

Get in touch
  • Contact
  • Careers
  • Contact
  • Careers
  • 250 590 3968
  • 250 590 3968

Follow us on :

X-twitter Linkedin
  • Privacy Policy
  • Terms of Use
  • IR Email Alerts
  • Do Not Sell or Share My Personal Information
  • Privacy Policy
  • Terms of Use
  • IR Email Alerts
  • Do Not Sell or Share My Personal Information
© 2025 Eupraxia Pharmaceuticals Inc. All rights reserved.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}